Download Citation
Article Source:
Comparison of safety profiles for dapagliflozin based on EMA and FDA safety issues: Challenges and future of post-marketing surveillance in Korea
Park S,
Kim HJ,
Won H,
Lee HE,
Cho H,
et al.
(2024)
Comparison of safety profiles for dapagliflozin based on EMA and FDA safety issues: Challenges and future of post-marketing surveillance in Korea.
PLOS ONE 19(11): e0314363.
https://doi.org/10.1371/journal.pone.0314363